Streetbeat News

Stock Prices

LULU

Investors have shown a bullish stance on Lululemon Athletica (NASDAQ:LULU) with significant options trading activity. Benzinga's options scanner identified 12 uncommon options trades, with a mix of bullish and bearish sentiments. Analysts have set an average price target of $430.2 for LULU, with ratings ranging from Buy to Market Perform.

Portfolio Pulse from Benzinga Insights

June 21, 2024 | 5:01 pm

RYAN

Ryan Specialty shares are trading higher following the announcement that the company will join the S&P MidCap 400.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 5:01 pm

PATH

UiPath (NYSE:PATH) has been analyzed by 17 analysts in the last three months, showing a range of perspectives from bullish to bearish. The average 12-month price target has dropped by 35.73% to $17.18. Analysts have predominantly lowered their ratings and price targets, reflecting a cautious outlook on the stock.

Portfolio Pulse from Benzinga Insights

June 21, 2024 | 5:01 pm

HRMY

Over the past three months, 7 analysts have shared their insights on Harmony Biosciences (NASDAQ:HRMY), with ratings ranging from bullish to somewhat bullish. The average 12-month price target is $49.71, slightly down from the previous $50.00. Analysts have maintained or raised their ratings, reflecting positive sentiment. Harmony Biosciences has shown strong revenue growth and profitability but faces challenges in return on equity.

Portfolio Pulse from Benzinga Insights

June 21, 2024 | 5:00 pm

DHR

Danaher (NYSE:DHR) has significantly outperformed the market over the past 10 years, delivering an average annual return of 16.87%. An initial $100 investment in DHR stock 10 years ago would be worth $473.11 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

June 21, 2024 | 5:00 pm

HON

Honeywell Intl (NASDAQ:HON) has outperformed the market over the past 20 years with an average annual return of 9.52%, resulting in a $100 investment growing to $621.15. The company currently has a market capitalization of $139.93 billion.

Portfolio Pulse from Benzinga Insights

June 21, 2024 | 5:00 pm

CNC

Over the past three months, 11 analysts have shared their evaluations of Centene (NYSE:CNC), revealing a range of outlooks from bullish to bearish. The average 12-month price target is $92.64, a slight decrease from the previous $94.44. Analysts have maintained, raised, or lowered their ratings and price targets based on recent developments. Centene has shown positive revenue growth and strong profitability metrics but faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

June 21, 2024 | 5:00 pm

SRPT

The FDA has expanded the approval of Sarepta Therapeutics Inc's (NASDAQ:SRPT) Elevidys to include individuals with Duchenne muscular dystrophy (DMD) who are at least four years old. This expansion is expected to lead to rapid uptake and substantial revenue growth for Sarepta. William Blair reiterates an Outperform rating with a fair value estimate of $210 per share. The approval is a significant milestone for Sarepta's DMD franchise and validates its gene therapy platform.

Portfolio Pulse from Vandana Singh

June 21, 2024 | 4:50 pm

D

Dominion Energy (NYSE:D) has seen an 18.09% increase in short interest, with 18.61 million shares sold short, representing 2.22% of its float. This is lower than the peer group average of 3.12%. The increase in short interest could indicate bearish sentiment, but it doesn't necessarily mean the stock will fall in the near term.

Portfolio Pulse from Benzinga Insights

June 21, 2024 | 4:45 pm

SOUN

SoundHound AI (NYSE:SOUN) has seen a 4.18% increase in its short percent of float, now at 23.91%. This indicates a bearish sentiment among investors, as it has a higher short interest compared to its peers. It would take traders 3.29 days to cover their short positions.

Portfolio Pulse from Benzinga Insights

June 21, 2024 | 4:45 pm